Sophiris Bio Announces Nasdaq Delisting
March 10, 2020 16:01 ET
|
Sophiris Bio, Inc.
SAN DIEGO and VANCOUVER, British Columbia, March 10, 2020 (GLOBE NEWSWIRE) -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin...
Sophiris Bio Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights
November 07, 2019 16:05 ET
|
Sophiris Bio, Inc.
SAN DIEGO and VANCOUVER, British Columbia, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Sophiris Bio Inc. (NASDAQ: SPHS), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class,...